The FDA has approved the inclusion of new evidence to the prescribing label for secukinumab for the treatment of psoriatic arthritis.   READ MORE

Collaborating Associations

Business Insider Series

This article describes the current federal policy debate regarding compounding and offers suggestions on how physicians can make their voices heard.

Aesthetics Corner

Antioxidants plus devices yield optimal aesthetic outcomes.